U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
EXIDAVNEMAB
INN  
Official Name English
IMMUNOGLOBULIN G4 (226-PROLINE), ANTI-(HUMAN .ALPHA.-SYNUCLEIN) (HUMAN-MUS MUSCULUS MONOCLONAL PR-1808164 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL PR-1808164 .KAPPA.-CHAIN, DIMER
Common Name English
exidavnemab [INN]
Common Name English
Code System Code Type Description
FDA UNII
BHV7HS9CF3
Created by admin on Sat Dec 16 14:51:32 GMT 2023 , Edited by admin on Sat Dec 16 14:51:32 GMT 2023
PRIMARY
INN
11775
Created by admin on Sat Dec 16 14:51:32 GMT 2023 , Edited by admin on Sat Dec 16 14:51:32 GMT 2023
PRIMARY
NCI_THESAURUS
C184863
Created by admin on Sat Dec 16 14:51:32 GMT 2023 , Edited by admin on Sat Dec 16 14:51:32 GMT 2023
PRIMARY
CAS
2438229-02-6
Created by admin on Sat Dec 16 14:51:32 GMT 2023 , Edited by admin on Sat Dec 16 14:51:32 GMT 2023
PRIMARY
ACTIVE MOIETY
EXIDAVNEMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966